In a nutshell This study investigated how common depression is in patients with type 2 diabetes (T2D). The main finding was that 20% of patients with T2D also have depression. Some background The number of people with T2D is constantly increasing. Previous studies have shown that mental health disorders, such as depression are more common in people...
Read More
In a nutshell This study investigated the effectiveness of LeucoPatch on hard-to-heal foot ulcers in patients with diabetes. The main finding of the study was that LeucoPatch enhanced the healing of diabetic foot ulcers. Some background Foot ulcers are a common and serious complication of diabetes. These ulcers can be very difficult to heal and can...
Read More
In a nutshell This study investigated the safety and effectiveness of albiglutide (Tanzeum) in preventing cardiovascular events (CVE) such as heart attacks and strokes in patients with type 2 diabetes (T2D) and heart disease. The main finding was that albiglutide reduced the risk of CVE in these patients. Some background Patients with...
Read More
In a nutshell This study investigated the safety and effectiveness of a new fast-acting insulin aspart at mealtimes and after meals as compared to traditional mealtime insulin in patients with type 1 diabetes (T1D). The main finding was that the fast-acting insulin aspart effectively controlled blood sugar levels in...
Read More
In a nutshell This study aimed to see if lorcaserin (Belviq), a drug that reduces appetite, can prevent and reverse type 2 diabetes (T2D). The main finding of the study was that lorcaserin decreases the risk of T2D and reverses T2D in overweight patients. Some background There is a significant link between obesity and T2D. Therefore, lowering...
Read More
Here is an infographic of heart facts with some surprises from the Cleveland Clinic....
Read More
In a nutshell This study investigated the effectiveness and safety of a new drug, LY3298176 for patients with Type 2 diabetes (T2D). The main finding of the study is that LY3298176 improved blood sugar control and was safe to use in these patients. Some background Insulin is a hormone that controls blood sugar. Patients with type 2 diabetes...
Read More
In a nutshell This study aimed to see if a closed-loop insulin delivery system (an automatic insulin delivery system) could control blood sugar levels better than the traditional patient-controlled insulin pump in patients with type 1 diabetes (T1D). The main finding was that the closed-loop insulin delivery system improved blood sugar...
Read More
In a nutshell This article provided guidelines for the management of hyperglycemia (high blood glucose levels) in patients with Type 2 diabetes (T2D). Some background The goals of T2D treatment are to prevent or delay complications and maintain a patient’s quality of life. Management of hyperglycemia and cardiovascular (heart and blood vessels)...
Read More
In a nutshell This study investigated if giving empagliflozin (Jardiance) in addition to normal insulin therapy to patients with Type 1 Diabetes (T1D) could help to better control blood sugar. They found that empagliflozin and insulin together improved blood sugar control and helped weight loss in patients with T1D. Some background The aim of...
Read More
In a nutshell This study evaluated the optimal blood pressure (BP) control in patients with diabetes. This study concluded that intensive BP therapy was associated with a significantly lower risk for cardiovascular events. Some background Uncontrolled BP remains a leading cause of cardiovascular diseases and death in patients with diabetes. Ideal BP...
Read More
In a nutshell This study looked at the effect lixisenatide (Lyxumia, Adlyxin) has on the kidneys in patients with both type 2 diabetes (T2D) and heart disease. The main finding was that lixisenatide reduced the development of kidney disease in these patients. Some background Patients with T2D have high levels of sugar in their blood. This sugar gets...
Read More
